GenSight Biologics S.A.
GSGTF
$0.19
-$0.05-20.79%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.43% | 25.05% | -7.85% | 15.64% | 3.04% |
| Total Depreciation and Amortization | -0.47% | 75.51% | 7.85% | -65.06% | -3.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.43% | 817.49% | 7.90% | -67.11% | -3.03% |
| Change in Net Operating Assets | 0.43% | -178.60% | 7.84% | 151.09% | -3.03% |
| Cash from Operations | 0.43% | -181.14% | -7.84% | 56.59% | 3.04% |
| Capital Expenditure | 0.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -0.43% | 560.13% | -7.89% | -1,133.33% | 0.00% |
| Cash from Investing | -0.44% | 552.49% | -7.89% | -1,133.33% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -154.24% | 0.00% | 85.77% | 0.00% |
| Issuance of Common Stock | 0.00% | 652.90% | 0.00% | -85.57% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 7,006.78% | 0.00% | 94.73% | 0.00% |
| Cash from Financing | -0.43% | 2,756.88% | 7.89% | -78.18% | -3.04% |
| Foreign Exchange rate Adjustments | 5.56% | -140.00% | 7.14% | 102.65% | 3.06% |
| Miscellaneous Cash Flow Adjustments | 0.00% | 200.00% | -20.00% | -200.00% | -16.67% |
| Net Change in Cash | -0.43% | 200.76% | -7.85% | 51.61% | 3.04% |